462 related articles for article (PubMed ID: 9846198)
1. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
3. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
4. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
6. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
7. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
[TBL] [Abstract][Full Text] [Related]
9. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
10. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
[TBL] [Abstract][Full Text] [Related]
11. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
14. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
[TBL] [Abstract][Full Text] [Related]
15. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
17. Proliferation measurement in breast cancer by two different methods.
Martínez-Arribas F; Martín-Garabato E; Lafuente P; Tejerina A; Lucas R; Sánchez J; Schneider J
Anticancer Res; 2006; 26(1A):199-202. PubMed ID: 16475699
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
19. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
[TBL] [Abstract][Full Text] [Related]
20. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
Wells SJ; DeRose PB; Cohen C
Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]